146 related articles for article (PubMed ID: 20932324)
1. p27(Kip1) deficiency promotes prostate carcinogenesis but does not affect the efficacy of retinoids in suppressing the neoplastic process.
Taylor W; Mathias A; Ali A; Ke H; Stoynev N; Shilkaitis A; Green A; Kiyokawa H; Christov K
BMC Cancer; 2010 Oct; 10():541. PubMed ID: 20932324
[TBL] [Abstract][Full Text] [Related]
2. A critical role for p27kip1 gene dosage in a mouse model of prostate carcinogenesis.
Gao H; Ouyang X; Banach-Petrosky W; Borowsky AD; Lin Y; Kim M; Lee H; Shih WJ; Cardiff RD; Shen MM; Abate-Shen C
Proc Natl Acad Sci U S A; 2004 Dec; 101(49):17204-9. PubMed ID: 15569926
[TBL] [Abstract][Full Text] [Related]
3. LncRNA GAS5 Inhibits Cellular Proliferation by Targeting P27
Luo G; Liu D; Huang C; Wang M; Xiao X; Zeng F; Wang L; Jiang G
Mol Cancer Res; 2017 Jul; 15(7):789-799. PubMed ID: 28396462
[TBL] [Abstract][Full Text] [Related]
4. Reduced expression of the CDK inhibitor p27(KIP1) in rat two-stage bladder carcinogenesis and its association with expression profiles of p21(WAF1/Cip1) and p53.
Lee CC; Ichihara T; Yamamoto S; Wanibuchi H; Sugimura K; Wada S; Kishimoto T; Fukushima S
Carcinogenesis; 1999 Sep; 20(9):1697-708. PubMed ID: 10469613
[TBL] [Abstract][Full Text] [Related]
5. Susceptibility of p27 kip1 knockout mice to urinary bladder carcinogenesis induced by N-butyl-N-(4-hydroxybutyl)nitrosamine may not simply be due to enhanced proliferation.
Hikosaka A; Ogawa K; Sugiura S; Asamoto M; Takeshita F; Sato SY; Nakanishi M; Kohri K; Shirai T
Int J Cancer; 2008 Mar; 122(6):1222-8. PubMed ID: 18027869
[TBL] [Abstract][Full Text] [Related]
6. Expression of p27/Kip1 is down-regulated in human prostate carcinoma progression.
Fernández PL; Arce Y; Farré X; Martínez A; Nadal A; Rey MJ; Peiró N; Campo E; Cardesa A
J Pathol; 1999 Apr; 187(5):563-6. PubMed ID: 10398122
[TBL] [Abstract][Full Text] [Related]
7. Induction of cell cycle arrest and apoptosis in human prostate carcinoma cells by a recombinant adenovirus expressing p27(Kip1).
Katner AL; Hoang QB; Gootam P; Jaruga E; Ma Q; Gnarra J; Rayford W
Prostate; 2002 Sep; 53(1):77-87. PubMed ID: 12210483
[TBL] [Abstract][Full Text] [Related]
8. Retinoic acid-mediated G1 arrest is associated with induction of p27(Kip1) and inhibition of cyclin-dependent kinase 3 in human lung squamous carcinoma CH27 cells.
Hsu SL; Hsu JW; Liu MC; Chen LY; Chang CD
Exp Cell Res; 2000 Aug; 258(2):322-31. PubMed ID: 10896783
[TBL] [Abstract][Full Text] [Related]
9. Role of Genetic Variations in
Híveš M; Jurečeková J; Kliment J; Grendár M; Kaplán P; Dušenka R; Evin D; Vilčková M; Holečková KH; Sivoňová MK
Cancer Genomics Proteomics; 2022; 19(3):362-371. PubMed ID: 35430569
[TBL] [Abstract][Full Text] [Related]
10. Impairment of the p27kip1 function enhances thyroid carcinogenesis in TRK-T1 transgenic mice.
Fedele M; Palmieri D; Chiappetta G; Pasquinelli R; De Martino I; Arra C; Palma G; Valentino T; Pierantoni GM; Viglietto G; Rothstein JL; Santoro M; Fusco A
Endocr Relat Cancer; 2009 Jun; 16(2):483-90. PubMed ID: 19261681
[TBL] [Abstract][Full Text] [Related]
11. Retinoids inhibit proliferation of human coronary smooth muscle cells by modulating cell cycle regulators.
Wakino S; Kintscher U; Kim S; Jackson S; Yin F; Nagpal S; Chandraratna RA; Hsueh WA; Law RE
Arterioscler Thromb Vasc Biol; 2001 May; 21(5):746-51. PubMed ID: 11348869
[TBL] [Abstract][Full Text] [Related]
12. Loss of the cyclin-dependent kinase inhibitor p27(Kip1) protein in human prostate cancer correlates with tumor grade.
Guo Y; Sklar GN; Borkowski A; Kyprianou N
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2269-74. PubMed ID: 9815624
[TBL] [Abstract][Full Text] [Related]
13. [Correlation of Skp2 and P27kip1 protein expression and clinicopathological features of prostate cancer].
Zheng XY; Ding W; Xie LP; Chen ZD
Ai Zheng; 2004 Feb; 23(2):215-8. PubMed ID: 14960249
[TBL] [Abstract][Full Text] [Related]
14. Expression of p27((Kip1)), cyclin D3 and Ki67 in BPH, prostate cancer and hormone-treated prostate cancer cells.
Nikoleishvili D; Pertia A; Trsintsadze O; Gogokhia N; Managadze L; Chkhotua A
Int Urol Nephrol; 2008; 40(4):953-9. PubMed ID: 18317945
[TBL] [Abstract][Full Text] [Related]
15. Genetic characterization of p27(kip1) and stathmin in controlling cell proliferation in vivo.
Berton S; Pellizzari I; Fabris L; D'Andrea S; Segatto I; Canzonieri V; Marconi D; Schiappacassi M; Benevol S; Gattei V; Colombatti A; Belletti B; Baldassarre G
Cell Cycle; 2014; 13(19):3100-11. PubMed ID: 25486569
[TBL] [Abstract][Full Text] [Related]
16. Nkx3.1 and p27(KIP1) cooperate in proliferation inhibition and apoptosis induction in human androgen-independent prostate cancer cells.
Wang P; Ma Q; Luo J; Liu B; Tan F; Zhang Z; Chen Z
Cancer Invest; 2009 May; 27(4):369-75. PubMed ID: 19266349
[TBL] [Abstract][Full Text] [Related]
17. MiR-196a is upregulated in gastric cancer and promotes cell proliferation by downregulating p27(kip1).
Sun M; Liu XH; Li JH; Yang JS; Zhang EB; Yin DD; Liu ZL; Zhou J; Ding Y; Li SQ; Wang ZX; Cao XF; De W
Mol Cancer Ther; 2012 Apr; 11(4):842-52. PubMed ID: 22343731
[TBL] [Abstract][Full Text] [Related]
18. miR-196a-mediated downregulation of p27
Zhan B; Huang L; Chen Y; Ye W; Li J; Chen J; Yang S; Jiang W
Prostate; 2020 Sep; 80(12):1024-1037. PubMed ID: 32628792
[TBL] [Abstract][Full Text] [Related]
19. p27Kip1 repression of ErbB2-induced mammary tumor growth in transgenic mice involves Skp2 and Wnt/beta-catenin signaling.
Hulit J; Lee RJ; Li Z; Wang C; Katiyar S; Yang J; Quong AA; Wu K; Albanese C; Russell R; Di Vizio D; Koff A; Thummala S; Zhang H; Harrell J; Sun H; Muller WJ; Inghirami G; Lisanti MP; Pestell RG
Cancer Res; 2006 Sep; 66(17):8529-41. PubMed ID: 16951165
[TBL] [Abstract][Full Text] [Related]
20. Novel 20-epi-vitamin D3 analog combined with 9-cis-retinoic acid markedly inhibits colony growth of prostate cancer cells.
Elstner E; Campbell MJ; Munker R; Shintaku P; Binderup L; Heber D; Said J; Koeffler HP
Prostate; 1999 Aug; 40(3):141-9. PubMed ID: 10398275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
